01—Abstract
Summary
Summary of the 8-K filed March 9, 2026. Cited figures are marked; the original filing is the authoritative source.
UnitedHealth Group Inc. (UNH) has filed an 8-K report on March 9, 2026, primarily to announce upcoming participation in the Barclays 28th Annual Global Healthcare Conference.
Senior leaders are scheduled to discuss the company's strategy, market positions, recent performance, and outlook for its end markets during an interview format on March 10, 2026. This provides an opportunity for investors to gain further insights into UNH's business and future expectations directly from its leadership.
02—Key points
Key Highlights
- UnitedHealth Group Inc. (UNH) announced participation in the Barclays 28th Annual Global Healthcare Conference.
- Senior leadership will engage in an interview format at the conference.
- Topics to be discussed include company strategy, market positions, recent results, and end market expectations.
- The conference presentation is scheduled for Tuesday, March 10, 2026, at 11:30 a.m. Eastern Time.
- A live audio webcast will be available on the Investor Relations section of the UNH website.
- This filing serves as a disclosure under Regulation FD, ensuring broad dissemination of information.
03—Questions
Frequently Asked Questions
What is the main purpose of this 8-K filing?
The primary purpose of this 8-K filing is to inform investors about UnitedHealth Group's participation in the Barclays 28th Annual Global Healthcare Conference and the timing of a presentation by senior leadership.
When and where can I access information from the conference presentation?
The presentation will take place on March 10, 2026, starting at 11:30 a.m. Eastern Time. A live audio webcast will be accessible through the Investor Relations page on the UnitedHealth Group website (www.unitedhealthgroup.com).
What specific topics will be covered by UnitedHealth Group's leadership?
Senior leaders are expected to discuss UnitedHealth Group's strategy, its competitive market positions, recent financial results, and their outlook or expectations for the company's various end markets.
Is the information presented at the conference considered 'filed' with the SEC?
No, the information provided in this Item 7.01 of the 8-K is not considered 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, nor is it automatically incorporated by reference into other SEC filings, unless specifically stated otherwise in a future filing.
04—Continue